Pharvaris N.V. (PHVS) vs Vericel Corporation (VCEL)

• Pharvaris N.V. PHVS 34.72 ▲ +6.73%
• Vericel Corporation VCEL 53.73 ▲ +3.77%

Pharvaris N.V. and Vericel Corporation are both Biotechnology companies. Vericel Corporation is the larger, with a market value of $2.7B against $2.3B — 1.2× the size. Pharvaris N.V. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 77.8×. Vericel Corporation has the higher net margin (10.3% vs 0.00%) and the higher return on invested capital (7.88% vs 0.00%). Across the 15 metrics below, Vericel Corporation leads on 13 and Pharvaris N.V. on 2.